Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 2—February 2009

Research

Medical Procedures and Risk for Sporadic Creutzfeldt-Jakob Disease, Japan, 1999–2008

Tsuyoshi Hamaguchi, Moeko Noguchi-Shinohara, Ichiro Nozaki, Yosikazu Nakamura, Takeshi Sato, Tetsuyuki Kitamoto, Hidehiro Mizusawa, and Masahito YamadaComments to Author 
Author affiliations: Kanazawa University Graduate School of Medical Science, Kanazawa, Japan (T. Hamaguchi, M. Noguchi-Shinohara, I. Nozaki, M. Yamada); Jichi Medical University, Shimotsuke, Japan (Y. Nakamura); Kohnodai Hospital, Ichikawa, Japan (T. Sato); Tohoku University Graduate School of Medicine, Sendai, Japan (T. Kitamoto); Tokyo Medical and Dental University, Tokyo, Japan (H. Mizusawa); Creutzfeldt-Jakob Disease Surveillance Committee, Japan (Y. Nakamura, T. Sato, J. Mizusawa, T. Kitamoto, M. Yamada)

Main Article

Table 2

Diagnoses for 210 controls in case–control study of sCJD, Japan, 1999–2008*

Disease No. diagnoses
Encephalitis 27
Alzheimer disease 21
Frontotemporal dementia 15
Metabolic encephalopathy 15
Cerebrovascular disorders 12
Spinocerebellar degeneration 12
Corticobasal degeneration 9
Epilepsy 7
Psychiatric disorders 7
Hypoxic encephalopathy 7
Hashimoto encephalopathy 6
Dementia with Lewy bodies 6
Paraneoplastic syndrome 5
Mitochondrial encephalopathy 4
Malignant lymphoma 3
Other disorders 54

*sCJD, sporadic Creutzfeldt-Jakob disease.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO